Kazakhstan to adopt pharmaceutical industry development program
Medical masks and other personal protective equipment will be produced in Kazakhstan in accordance with special state standard. This was declared at a session on the development of domestic pharmaceutical industry during a working visit of Kazakh Prime Minister Askar Mamin to Karagandy region. He instructed Kazakh Ministry of Industry and Infrastructure Development to work out the pharmaceutical industry development program taking into account offers from the business community and submit its draft in September.
He informed that production volumes of pharmaceutical companies have increased by 23.2 percent over seven months of 2020, amounting to 70.2 billion tenge (US$166.3 million). “Growth points” of Kazakh pharmaceutical industry are currently located in Almaty and Shymkent cities as well as in Almaty and Karagandy regions. A total of 96 enterprises operate in this industry, 33 of them are producing medicines, 41 – medical devices and 22 – medical equipment. 41 projects with investment totaling 62.9 billion tenge (more than US$149 million) began working as part of the Industrialization Map.
“Kazakh pharmaceutical industry has a great potential for development. The main goal is to make a breakthrough in the domestic production of medicines and medical devices, ensuring sufficient stocks and expanding the range. The country’s population must have free access to high-quality medical products,” said Askar Mamin.
The PM set a task to put best prices on medicines in domestic market that will ensure affordability and quality for the population and a reasonable cost-effectiveness for business. He also instructed Kazakh Health Ministry together with “SK-Pharmacy” to review the mechanisms for planning the availability of medicines in medical institutions. He stressed the necessity to improve requirements for registration of medicines and introduction of a forecasting system of the procurement volume for local producers.